Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
The University of Leicester is seeking a research post-holder within the Becky Mayer Centre for Phage Research. This full-time role, which offers opportunities for impactful translational science, involves establishing scalable production of phages and engaging with both industry and academic partners. Candidates should hold (or be nearing completion of) a PhD and demonstrate relevant hands-on experience. The position offers competitive salary and professional development in a supportive environment.
About the role
The post-holder will be based within the Becky Mayer Centre for Phage Research at the University of Leicester.
With the rise of antimicrobial resistance, novel treatments are desperately needed. Bacteriophages, or phages, are viruses that attack bacterial cells and offer the potential as therapeutics to treat pathogenic bacterial infections.
Your role will be to establish and optimise the pipeline for scalable phage production to produce high quality and high titre phage. You will work collaboratively with researchers in industry and academia, and independently as part of a research team to achieve defined milestones and produce high quality research as part of the wider programme.
About you
You will hold (or be close to completing) a PhD in a relevant discipline and bring hands-on experience of scaling up microbial product production, ideally including viruses or protein complexes. Your knowledge of GMP processes, coupled with your ability to problem-solve and work both independently and within a team, will be essential. You should also have a solid track record of producing high-quality research outputs and be enthusiastic about contributing to impactful translational science.Additional information
Informal enquiries are welcome and should be made toProf Martha Clokie or Assoc Prof Andy Millard, Centre for Phage Research,centre4phageresearch@leicester.ac.uk
Vacancy terms
Full-time, or job share considered, fixed term contract until 31 March 2027